title: Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress.
abstract: A "longevity " gene, sirtuin 1 (SIRT1), can attenuate age-dependent induction of left ventricular dysfunction. This study aimed to characterize the role of SIRT1 in the tolerance of aged heart to ischemic insults. Male C57BL/6 young (4-6 mo) and aged (24-26 mo) mice were used to determine the role of SIRT1 in myocardial ischemia/reperfusion (I/R) tolerance. SIRT1 localization was assessed by confocal microscopy. Immunoblotting was used to evaluate SIRT1 expression and translocation. The results demonstrated that SIRT1 is expressed predominantly as a sumoylated form in cardiomyocyte nuclei. Moreover, cardiac overexpression of desumoylase, sentrin-specific protease 2 (SENP2), significantly reduces nuclear sumoylated SIRT1 levels (P<0.05). Interestingly, I/R stress leads to desumoylation and translocation of nuclear SIRT1 into the cytoplasm in aged but not in young hearts. SIRT1 activity in ischemic young hearts was 3.2-fold higher than that seen in ischemic aged hearts, which suggests that aging causes impaired nucleocytoplasmic shuttling and activation of SIRT1 during ischemic stress. The infarct size in aged and Sirt1(+/-) knockout hearts was higher than that observed in young and Sirt1(+/+) WT littermate hearts, respectively (all P<0.05). SIRT1 agonist, SRT1720, reduced myocardial infarction in both aged and Sirt1(+/-) hearts. Therefore, impaired cardiac SIRT1 activity plays a critical role in the observed increase in susceptibility of the aged heart to I/R injury. SIRT1 agonist can restore this aging-related loss of cardioprotection.
authors.affiliation: 1615 Biomedical Research Bldg., Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences University at Buffalo-SUNY, 3435 Main St., Buffalo, NY 14214, USA. jli23@buffalo.edu.
authors.forename: Chao
authors.initials: C
authors.lastname: Tong
authors.forename: Alex
authors.initials: A
authors.lastname: Morrison
authors.forename: Samantha
authors.initials: S
authors.lastname: Mattison
authors.forename: Su
authors.initials: S
authors.lastname: Qian
authors.forename: Mark
authors.initials: M
authors.lastname: Bryniarski
authors.forename: Bethany
authors.initials: B
authors.lastname: Rankin
authors.forename: Jun
authors.initials: J
authors.lastname: Wang
authors.forename: D Paul
authors.initials: DP
authors.lastname: Thomas
authors.forename: Ji
authors.initials: J
authors.lastname: Li
mesh_terms: D021581:Active Transport, Cell Nucleus; D000367:Age Factors; D000375:Aging; D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism*; D003546:Cysteine Endopeptidases / Q000235:genetics / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D006321:Heart / Q000254:growth & development*; D006576:Heterocyclic Compounds, 4 or More Rings / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism*; D015428:Myocardial Reperfusion Injury / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000378:metabolism*; D021381:Protein Transport; D056564:Sirtuin 1 / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D013312:Stress, Physiological; D058207:Sumoylation
chemical_list: D006576:Heterocyclic Compounds, 4 or More Rings; C525422:SRT1720; D003546:Cysteine Endopeptidases; C439066:Senp2 protein, mouse; C470545:Sirt1 protein, mouse; D056564:Sirtuin 1